Hamster thoracic aortas displayed rhythmic oscillations in active tension when stimulated with the αi-adrenergic agonist, phenylephrine, prostaglandin F (PGF), and a number of other agonists, but not when activated with K+. These oscillations were not affected by adrenergic or cholinergic antagonists, or an inhibitor of prostaglandin synthesis. However, removal of the endothelium from these vessels eliminated this rhythmic activity. Furthermore, exposure to methylene blue or hemoglobin (known inhibitors of endothelium-dependent phenomena) significantly reduced the amplitude and the frequency of the oscillations. Removal of extracellular calcium ions or treatment with the calcium channel blocker, verapamil, also inhibited the oscillations even when active tension was maintained. These data suggest that the oscillations in agonist-induced active tension depend on a functional endothelium, and possibly an endothelium-derived factor, and the influx of extracellular calcium. This study also demonstrates that, like most other species, hamster aortas display endothelium-dependent relaxation to muscarinic agonists, such as methacholine, and the calcium ionophore A23187.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.